TARE / SIRT (radioembolisation with yttrium-90)
Injecting tiny radioactive glass or resin beads into the liver's artery so they lodge in the tumour and irradiate it from inside.
Yttrium-90 microspheres (20-60 µm) deliver beta radiation over a few millimetres with a 64-hour half-life, treating hepatocellular carcinoma, colorectal liver metastases and neuroendocrine liver metastases. Randomised trials against sorafenib (SARAH, SIRveNIB) showed no survival gain but better tolerability; radiation segmentectomy, which delivers ablative doses to a small segment, achieves outcomes close to ablation. Dosimetry now individualises the activity (DOSISPHERE). Chosen over TACE when portal vein thrombus is present.
Pages like this
not linked directly; found by shared links- TermBCLC staging
Shares Portal vein tumour thrombus (macrovascular invasion), TACE (transarterial chemoembolisation), Transarterial chemoembolisation (TACE), Hepatocellular carcinoma.
- CompanyBoston Scientific
Shares Transarterial chemoembolisation (TACE), Hepatocellular carcinoma, Colorectal cancer.
- TechnologyPercutaneous hepatic perfusion (chemosaturation)
Shares Liver-directed therapy (TACE, TARE, HAI, ablation), Transarterial chemoembolisation (TACE), Neuroendocrine tumours.
- TrialEMERALD-1
Shares Transarterial chemoembolisation (TACE), Hepatocellular carcinoma.
- TermCirrhosis
Shares Portal vein tumour thrombus (macrovascular invasion), Hepatocellular carcinoma.
- TermDownstaging and conversion therapy
Shares Transarterial chemoembolisation (TACE), Hepatocellular carcinoma, Colorectal cancer.
- TermHepatectomy (liver resection)
Shares Liver-directed therapy (TACE, TARE, HAI, ablation), Hepatocellular carcinoma, Colorectal cancer.
- TrialLEAP-012
Shares Transarterial chemoembolisation (TACE), Hepatocellular carcinoma.